RECITALSSettlement and Modification Agreement • December 21st, 2004 • Vitrotech Corp • Mining & quarrying of nonmetallic minerals (no fuels) • California
EX-10.20 5 a2212752zex-10_20.htm EX-10.20 [***] INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2...Settlement and Modification Agreement • May 5th, 2020 • Delaware
THIS SETTLEMENT AND MODIFICATION AGREEMENT (the “Settlement Agreement”), effective as of the date upon which all parties have signed below (the “Effective Date”), is by and between ASIVI, LLC, a Delaware limited liability company, with offices at 1172 Castro Street, Mountain View, California 94040 (“ASIVI”), VIVUS, INC., a Delaware corporation with a principal place of business at 1172 Castro Street, Mountain View, California 94040 (“VI”), ANDROSOLUTIONS, INC., a Tennessee corporation with a principal place of business at Suite 309, 200 Fort Sanders West Blvd., Knoxville, TN 37922 (collectively with its Affiliates, “ASI”), and Gary W. Neal, M.D., a natural person residing at 4701 Guinn Road, Knoxville, TN 37931 (“GWN”).
CONFIDENTIAL SETTLEMENT AND MODIFICATION AGREEMENTSettlement and Modification Agreement • February 25th, 2021 • Anaptysbio, Inc • Pharmaceutical preparations • Delaware
This Confidential Settlement and Modification Agreement (the “Agreement”) is made and entered into on the date that it is signed by the last of the signatories identified below (the “Effective Date”), by and between (i) AnaptysBio, Inc., a Delaware corporation having its principal place of business at 10421 Pacific Center Court, Suite 200, San Diego, CA 92121 (“AnaptysBio”), (ii) Tesaro, Inc., a Delaware corporation having its principal place of business in 1000 Winter Street, Waltham, Massachusetts 02451, (iii) Tesaro Development, Ltd., a Bermuda corporation having its principal office at Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda (together with Tesaro, Inc., “Tesaro”), and (iv) GlaxoSmithKline LLC, a Delaware limited liability corporation having its principal place of business at 5 Crescent Drive, Philadelphia, PA 19112 (“GSK”) (Tesaro and GSK, collectively, “Defendants”) (each individually the “Party” or collectively the “Parties”).
BACKGROUNDSettlement and Modification Agreement • August 9th, 2001 • Vivus Inc • Surgical & medical instruments & apparatus • Delaware
